Stocktoria
Aardvark Therapeutics, Inc. AARD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-02-13
Aardvark Therapeutics, Inc. statistics & valuation
Market cap$104.5M
P / B1.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -49.1% | -26.6% |
| Return on equity | -54.0% | 37.7% |
| Current ratio | 10.61 | 15.05 |
Source: SEC EDGAR filings · CIK 0001774857 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.